Scarica l'app Stockscreener
51.74
2.15%
1.09
Dopo l'orario di chiusura:
51.74
Tarsus Pharmaceuticals Inc Borsa (TARS) Ultime notizie
Fastest-Growing Public Cos. Ride Healthcare Boom - Orange County Business Journal
Tarsus Pharmaceuticals CEO sells $300,000 in stock - Investing.com India
Where are the Opportunities in (TARS) - Stock Traders Daily
Tarsus Pharmaceuticals CFO Jeffrey Farrow sells $178,306 in stock By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals CEO Bobak Azamian sells $1.16 million in stock By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals COO Neervannan Seshadri sells $363,141 in stock By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals chief commercial officer sells $505,856 in stock By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals’ general counsel sells shares worth $463,765 By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals CFO Jeffrey Farrow sells $178,306 in stock - Investing.com
Tarsus Pharmaceuticals’ general counsel sells $463,765 in stock - Investing.com India
Tarsus Pharmaceuticals CEO Bobak Azamian sells $1.16 million in stock - Investing.com
Tarsus Pharmaceuticals’ general counsel sells shares worth $463,765 - Investing.com
Tarsus Pharmaceuticals chief commercial officer sells $505,856 in stock - Investing.com
Tarsus Pharmaceuticals’ HR chief sells shares worth $321,323 - Investing.com
Tarsus Pharmaceuticals COO Neervannan Seshadri sells $363,141 in stock - Investing.com
Tarsus Pharmaceuticals Executives Sell Shares to Cover Tax Obligations - TradingView
Tarsus Pharmaceuticals completes $134.8M stock offering By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals completes $134.8M stock offering - Investing.com India
Tarsus prices $125M stock offering - MSN
Tarsus Pharma dips after upsized $125 mln stock offering - TradingView
Tarsus Pharmaceuticals Prices Upsized $125 Million Equity Offering -March 13, 2025 at 03:44 am EDT - Marketscreener.com
Tarsus Pharmaceuticals launches $100 million stock offering - Investing.com Australia
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering - GlobeNewswire
Tarsus Secures Massive $125M Capital Raise as Investors Rush Into Upsized Offering - StockTitan
Tarsus Announces Pricing Of Upsized $125 Million Public Offering -March 12, 2025 at 09:50 pm EDT - Marketscreener.com
Tarsus Pharmaceuticals dips on planned $100 million equity raise - TradingView
Tarsus Pharmaceuticals launches $100 million stock offering By Investing.com - Investing.com Canada
Tarsus Announces Proposed $100.0 Million Public Offering - The Manila Times
Tarsus Pharmaceuticals’ SWOT analysis: specialty pharma stock faces growth hurdles By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals’ SWOT analysis: specialty pharma stock faces growth hurdles - Investing.com
Tarsus Pharma: Strong Execution In Xdemvy Commercialization (NASDAQ:TARS) - Seeking Alpha
Oppenheimer & Co. Inc. Takes Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Up 5.8% Following Analyst Upgrade - Defense World
Contrasting PharmaCyte Biotech (OTCMKTS:PMCBD) & Tarsus Pharmaceuticals (NASDAQ:TARS) - Defense World
Tarsus to Participate in Upcoming Investor Conference - GlobeNewswire
Tarsus Pharmaceuticals Inc (TARS) to Participate in Barclays Global Healthcare Conference - GuruFocus.com
Healthcare Spotlight: Tarsus Takes Center Stage at Major Barclays Conference - StockTitan
Tarsus Pharmaceuticals price target raised to $58 from $54 at Jefferies - TipRanks
0.39%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):